Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (2): 238-242    DOI: 10.31083/j.ceog.2020.02.5149
Original Research Previous articles | Next articles
Prophylactic cervical cerclage, fully embedded, for twin pregnancies following fertility treatment
L. Mamas1(), E. Mamas1
1Neogenesis IVF Centre, Marousi, Athens, Greece
Download:  PDF(2045KB)  ( 89 ) Full text   ( 2 )
Export:  BibTeX | EndNote (RIS)      
Abstract  Purpose of Investigation: With the advent of fertility treatment the number of twin gestations has increased considerably. These pregnancies are associated with many maternal and perinatal complications, mainly due to prematurity. The aim of this study was to assess the effectiveness of a fully embedded prophylactic vaginal cervical cerclage in reducing the rate of prematurity in twin pregnancies following ART. Materials and Methods: A prophylactic vaginal cervical cerclage was applied in forty three twin pregnancies conceived following fertility treatments. The cerclage suture was fully embedded under the vaginal mucosa in order to minimize the risk of infection. Results: The mean gestational age at delivery was 35+4 weeks and the mean delivery weight was 2,238 grams. No differences between the type of fertility treatment used was noted in the outcome measures studied. Conclusion: Twin pregnancies conceived with the aid of fertility treatment, benefited from the application of a prophylactic vaginal cervical cerclage.
Key words:  Cervical cerclage      Twins      Premature delivery      Fertility treatment      ART     
Published:  15 April 2020     

Cite this article: 

L. Mamas, E. Mamas. Prophylactic cervical cerclage, fully embedded, for twin pregnancies following fertility treatment. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 238-242.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.02.5149     OR     https://ceog.imrpress.com/EN/Y2020/V47/I2/238

Table 1  — Number of twin pregnancies conceived by different fertility treatments.
ICSI 23 (53.5%)
IUTPI 14 (32.5%)
COS 6 (14%)
Total 43
Table 2  — Pregnancy and neonatal characteristics of twin pregnancies treated with prophylactic vaginal cervical cerclage.
ART method Neonatal gender
IVF IUTPI COS Female Male
Neonates (n) 46 28 12 48 38
Birthweight (g) 2213 2231 2347 2190 2298
GA (weeks) 35+1 35+6 35+5 N/A
NICU admissions (n) 26 (56%) 16 (57%) 7 (58%) 28 21
Length of NICU stay (days) 11 10 12 13 11
[1] De Geyter C., Calhaz-Jorge C., Kupka M.S., Wyns C., Mocanu E., Motrenko T., et al.: “European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE): “ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)”. Hum Reprod., 2018, 33, 1586.
doi: 10.1093/humrep/dey242 pmid: 30032255
[2] Sunderam S., Kissin D.M., Crawford S.B., Folger S.G., Boulet, S.L., Warner L., Barfield W.D.: “Assisted Reproductive Technology Surveillance — United States, 2015”. MMWR Surveill. Summ., 2018, 67, 1.
doi: 10.15585/mmwr.ss6701a1 pmid: 29346340
[3] Santolaya J., Faro R.: “Twins - twice more trouble?” Clin. Obstet. Gynecol., 2012, 55, 296.
doi: 10.1097/GRF.0b013e3182446f51
[4] Bamberg C., Fotopoulou C., Neissner P., Slowinski T., Dudenhausen J.W., Proquitte H. et al.: “Maternal characteristics and twin gestation outcomes over 10 years: impact of conception methods”. Fertil. Steril., 2012, 98, 95.
doi: 10.1016/j.fertnstert.2012.04.009 pmid: 22608318
[5] Källén B., Finnström O., Lindam A., Nilsson E., Nygren K.G., Olausson P.O.: “Selected neonatal outcomes in dizygotic twins after IVF versus non - IVF pregnancies”. BJOG, 2010, 117, 676.
doi: 10.1111/j.1471-0528.2010.02517.x pmid: 20184569
[6] Bromer J.G., Ata B., Seli M., Locdwood C.J., Seli E.: “Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA: a cost analysis”. Curr. Opin. Obstet. Gynecol., 2011, 23, 168.
doi: 10.1097/GCO.0b013e32834551cd pmid: 21372712
[7] Himpens E., Van den Broeck C., Oostra A., Calders P., Vanhaesebrouck P.: “Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review”. Dev. Med. Child. Neurol., 2008, 50, 334.
doi: 10.1111/j.1469-8749.2008.02047.x pmid: 18355333
[8] Maloni J.A., Margevicious S.P., Damato E.G.: “Multiple gestation: side effects of antepartum bed rest”. Biol. Res. Nurs., 2006, 8, 115.
doi: 10.1177/1099800406291455 pmid: 17003251
[9] Da Silva Lopes K, Takemoto Y., Ota E., Tanigaki S., Mori R.: “Bed rest with and without hospitalisation in multiple pregnancy for improving perinatal outcomes”. Cochrane Database Syst Rev., 2017, 3, CD012031.
doi: 10.1002/14651858.CD012031.pub2 pmid: 28262917
[10] Sotiriadis A., Papatheodorou S., Makrydimas G.: “Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis”. Ultrasound Obstet. Gynecol., 2012, 40, 257.
doi: 10.1002/uog.11178 pmid: 22611023
[11] Hernandez W.R., Francisco R.P.V., Bittar R.E., Gomez U.T., Zugaib M., Brizot M.L.: “Effect of vaginal progesterone in tocolytic therapy during preterm labor in twin pregnancies: Secondary analysis of a placebo-controlled randomized trial”. J. Obstet. Gynaecol. Res., 2017, 43, 1536.
doi: 10.1111/jog.13421 pmid: 28707771
[12] Dodd J.M., Grivell R.M., O’Brien C.M., Dowswell T., Deussen A. R., : “Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy”. Cochrane Database System Rev., 2017, 10, CD012024.
[13] Carreras E., Arévalo S., Bello-Muñoz J.C., Goya M., Rodó C., Sanchez-Duran M. A., et al.: “Arabin cervical pessary to prevent preterm birth in severe twin-to-twin transfusion syndrome treated by laser surgery”. Prenat. Diag., 2012, 32, 1181.
doi: 10.1002/pd.v32.12
[14] Nicolaides K.H., Syngelaki A., Poon L.C., de Paco Matallana C., Plasencia W., Molina F.S., et al.: “Cervical pessary placement for the prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial”. Am. J. Obstet. Gynecol., 2016, 214, e1.
[15] Shirodkar J.N.: “A new method for operative treatment of habitual abortions in the second trimester of pregnancy”. Antiseptic, 1955, 52, 299.
[16] McDonald I.A.: “Suture of the cervix for the inevitable miscarriage”. J. Obstet. Gynecol. Br. Emp., 1957, 64, 346.
doi: 10.1111/bjo.1957.64.issue-3
[17] Benson C.R., Durfee R.B.: “Transabdominal cervivouterine cerclage during pregnancy for the treatment of cervical incompetency”. Obstet. Gynecol., 1965, 25, 145.
pmid: 14268594
[18] Mamas L.: “Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study”. Fertil. Steril., 2006, 85, 735.
doi: 10.1016/j.fertnstert.2005.08.025
[19] Magann E.F., Haram K., Ounpraseuth S., Mortensen J.H., Spencer H.J., Morrison J.C.: “Use of antenatal corticosteroids in special circumstances: a comprehensive review” Acta Obstet. Gynecol. Scand., 2017, 96, 395.
doi: 10.1111/aogs.13104 pmid: 28130929
[20] Yamamoto R., Ishii K., Muto H., Ota S., Kawaguchi H., Hayashi S., Mitsuda N.: “Incidence of and risk factors for severe maternal complications associated with hypertensive disorders after 36 weeks' gestation in uncomplicated twin pregnancies: A prospective cohort study”. J. Obstet. Gynaecol. Res., 2018, 44, 1221.
doi: 10.1111/jog.13650 pmid: 29673002
[21] Moini A., Shiva M., Arabipoor R., Hosseini R., Chehrazi M., Sadeghi M.: “Obstetric and neonatal outcomes of twin pregnancies conceived by assisted reproductive technology compared with twin pregnancies conceived spontaneously: a prospective follow - up study”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2012, 165, 29.
doi: 10.1016/j.ejogrb.2012.07.008 pmid: 22884795
[22] Kalra S.K., Radcliffe S.J., Barnhart K.T., Coutifaris C.: “Extended embryo culture and an increased risk of preterm delivery”. Obstet. Gynecol., 2012, 120, 69.
doi: 10.1097/AOG.0b013e31825b88fc
[23] Ericson A., Nygren K.G., Olausson P.O., Källén B.: “Hospital care utilization of infants born after IVF”. Hum. Reprod., 2002, 17, 929.
doi: 10.1093/humrep/17.4.929 pmid: 11925384
[24] Rozenberg P., Sénat M.V., Gillet A., Ville Y.: “Comparison of two methods of cervical cerclage by ultrasound cervical measurement”. J. Matern. Fetal Neonatal Med., 2003, 13, 314.
doi: 10.1080/jmf.13.5.314.317 pmid: 12916681
[25] Wong C.H., Chen C.P., Wang K.G., Sun F.J., Chen C.Y.: “Compari-son of two cervical cerclages for the prevention of preterm birth and neonatal complications”. J. Matern. Fetal Neonatal Med., 2017, 30, 551.
doi: 10.1080/14767058.2016.1177818 pmid: 27072547
[26] Elimian A., Figueroa R., Nigam S., Verma U., Tejani N., Kirshenbaum N.: “Perinatal outcome of triplet gestation: does prophylactic cerclage make a difference?” J. Matern. Fetal Med., 1999, 8, 119.
[27] Ayman S., Hesham B., Naglaa H., Maher A.H.: “Prophylactic Cerclage in ICSI Twins: To Do or Not to Do? A Randomized Controlled Study”. Womens Health Gynecol., 2016, 2, 042.
[28] Skentou C., Souka A.P., To M.S., Liao A.W., Nicolaides K.H.: “Prediction of preterm delivery in twins by cervical assessment at 23 weeks”. Ultrasound Obstet. Gynecol., 2001, 17, 7.
doi: 10.1046/j.1469-0705.2001.00357.x pmid: 11244660
[29] Bergelin I., Valentin L.: “Cervical changes in twin pregnancies observed by transvaginal ultrasound during the latter half of the pregnancy: a longitudinal, observational study”. Ultrasound Obstet Gynecol, 2003, 21, 556
doi: 10.1002/uog.150 pmid: 12808672
[30] Gupta M., Emary K., Impey L.: “Emergency cervical cerclage: predictors of success”. J. Matern. Fetal Neonatal Med., 2010, 23, 670.
doi: 10.3109/14767050903387011 pmid: 19883267
[31] Blair O., Fletcher H., Kulkarni S.: “A randomized controlled trial of outpatient versus inpatient cervical cerclage”. J. Obstet. Gynaecol., 2002, 22, 493
doi: 10.1080/0144361021000003618 pmid: 12521415
[32] Charles D., Edwards W.R.: “Infectious complications of cervical cerclage”. Am. J. Obstet. Gynecol., 1981, 141, 1065.
doi: 10.1016/s0002-9378(16)32698-9 pmid: 7315918
[33] De Geyter C.:“Eight million IVF babiew since the birth of the world’s first in 1978 ”. 34th Annual ESHRE Meeting, Barcelona. https://www.focusonreproduction.eu/article/ESHRE News_GlobalIVFL8
[34] Pinborg A., Loft A., Rasmussen S., Schmidt L., Langhoff-Roos J., Greissen G., et al.: “Neonatal outcome in a Danish national cohort of 3439 IVF/ICSI and 10362 non-IVF/ICSI twins born between 1995 and 2000”. Hum. Reprod., 2004, 19, 435.
doi: 10.1093/humrep/deh063 pmid: 14747193
[35] Kruse M., Michelsen S.I., Flachs E.M., Brønnum-Hansen H., Madsen M., Uldall P.: “Lifetime costs of cerebral palsy”. Dev. Med. Child. Neurol., 2009, 51, 622.
doi: 10.1111/j.1469-8749.2008.03190.x pmid: 19416329
[36] Lee A.M., Connell M.T., Csokmay J.M., Styer A.K.: “Elective single embryo transfer- the power of one”. Contracept. Reprod. Med., 2016, 1, 11.
doi: 10.1186/s40834-016-0023-4 pmid: 29201400
[37] Ikemoto Y., Kyroda K., Ochiai A Yamashita S., Ikuma S., Nojiri S., et al.: “Prevalence and risk factors of zygotic splitting after 937 848 single embryo transfer cycles”. Hum. Reprod., 2018, 33, 1984.
doi: 10.1093/humrep/dey294 pmid: 30299468
[38] Blennborn M., Nilsson S., Hillervik C., Hellberg D.: “The couple’s decision-making in IVF: one or two embryos at transfer?” Hum. Reprod., 2005, 20, 1292.
doi: 10.1093/humrep/deh785 pmid: 15734759
[1] W.Q. Li, X.S. Deng, G.B. Li, Y.G. Kang. Feasibility of a three-dimensional rotational angiography road map for individualized guidance of uterine artery catheterization[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 687-692.
[2] S.H. Park, J. Lim, K.T. Lim, K.H. Choi, S.M. Yoon,H.J. Chung. Ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis, a type of limbic encephalitis: a review of the literature and a case report in korea[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 774-780.
[3] A. Theodoridou, A. Athanasiadis, G. Tsakmakidis, Ι. Tsakiridis, A. Pilavidi, C. Vosnakis, T. Dagklis, G. Mavromatidis, A. Mamopoulos. Current methods of non-invasive fetal heart rate surveillance[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 459-464.
[4] H.M. Kim, J.Y. Lee, W.J. Seong. Multidetector computed tomography to predict heavy bleeding and need for angiographic embolization in patients with postpartum hemorrhage[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 478-482.
[5] N. Matsumoto, Y. Mori. High fibrin/fibrinogen degradation product and D-dimer levels for the diagnosis of invasive group A streptococcal infections during pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 483-489.
[6] A. Daniilidis, G. Dryllis, G. Chorozoglou, M. Politou, R. Dampali, K. Dinas. Substitution of hemoglobin levels in pregnant women with iron supplement: A prospective randomized clinical study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 579-583.
[7] Y. Wang, X.Y. Lu, F. Xu, H.M. Huang, Y. Xu, X.W. Xi. Detection of uterine artery hemodynamic changes in patients with gestational hypertension based on Doppler ultrasonography[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 584-589.
[8] M. Ohta, N. Keira, S. Yoshida, R. Yasuda, Y. Tarumi, H. Tsuchiya, M. Kikai, T. Nomura, T. Tatsumi. The possible involvement of interleukin-6 in congestive heart failure in a postmenopausal woman with uterine fibromatosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 590-595.
[9] J.A. García-Mejido, C. Suarez-Serrano, E.M. Medrano-Sanchez, M.J. Bonomi Barby, A. Armijo Sánchez, J.A. Sainz. Pelvic floor rehabilitation in patients with levator ani muscle avulsion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 341-347.
[10] S. Coremans, J. Muys, J. De Winter, H. De Raedemaecker, Y. Jacquemyn. Ultrasound by midwives in the postpartum period: feasibility, reproducibility and midwives’ perspectives[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 348-354.
[11] K. Tamura, H. Takahashi, S. Uchida, M. Ogoyama, R. Usui, S. Matsubara. Intrauterine balloon failure: unrecognized placenta accreta spectrum disorders[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 405-408.
[12] T.N. Yu, Y.L. Liu, Y.X. Lee, C.R. Tzeng, C.H. Chen. Vibration-related ovarian torsion in a patient undergoing in vitro fertilization: A case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 415-418.
[13] S.L. Zheng, X. Zhang, J. Lai, X.S. Gao, X.Y. Wang. Lower limb (healthy leg) compartment syndrome after the patient was in the lithotomy position during the operation: a case study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 449-451.
[14] S. J. Knight, A. D. Smith, H. Kim, A. C. Collier. Human placental suppressors of cytokine signalling (SOCS) and inflammatory cytokines are dysregulated in assisted reproduction, advanced maternal age and pre-term birth[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 277-286.
[15] D. Yang, H.F. Zhang, Q. Liu, Y.N. Li, J. Zhang, T. Zheng. Pregnancy outcomes in women with congenitally corrected transposition of the great arteries[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 291-295.
No Suggested Reading articles found!